Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: A prospective study

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Eriksson, Anders ^a   Flach, Carl Fredrik ^b   Lindgren, Anders ^c   Kvifors, Eva ^a   Lange, Stefan ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Department of Internal Medicine ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; AZATHIOPRINE; ELAFIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GENE PRODUCT; MESALAZINE; PREDNISOLONE; PROTEIN MST 1; PROTEIN SIMNIPHOM; PROTEIN SLC6A14; UNCLASSIFIED DRUG; CARRIER PROTEIN; MACROPHAGE STIMULATING PROTEIN; ONCOPROTEIN; SCATTER FACTOR; SIMNIPHOM PROTEIN, HUMAN; SLC6A14 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CECUM; CLINICAL ARTICLE; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROTEIN ANALYSIS; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECTUM MUCOSA; ULCERATIVE COLITIS; BIOPSY; CASE CONTROL STUDY; GENETICS; METABOLISM; MIDDLE AGED; MUCOSA; PATHOLOGY; POLYMERASE CHAIN REACTION; RECTUM;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; BIOPSY; CARRIER PROTEINS; CASE-CONTROL STUDIES; CECUM; COLITIS, ULCERATIVE; ELAFIN; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RECTUM; TRANSCRIPTION, GENETIC;

EID: 51649119852     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-34     Document Type: Article

References (23)

1. Fiocchi C Inflammatory bowel disease: Etiology and pathogenesis Gastroenterology 1998, 115:182-205. 10.1016/S0016-5085(98)70381-6 9649475
2. Macdonald TT Monteleone G Immunity, inflammation, and allergy in the gut Science 2005, 307:1920-1925. 10.1126/science.1106442 15790845
3. Ekbom A Helmick C Zack M Adami HO The epidemiology of inflammatory bowel disease: A large, population-based study in Sweden Gastroenterology 1991, 100:350-358. 1985033
4. Moum B Vatn MH Ekbom A Aadland E Fausa O Lygren I Sauar J Schulz T Stray N Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists Scand J Gastroenterol 1996, 31:362-366. 10.3109/ 00365529609006411 8726304
5. Jacobsen BA Fallingborg J Rasmussen HH Nielsen KR Drewes AM Puho E Nielsen GL Sorensen HT Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: A population-based study, 1978-2002 Eur J Gastroenterol Hepatol 2006, 18:601-6. 10.1097/ 00042737-200606000-00005 16702848
6. Kucharzik T Maaser C Lugering A Kagnoff M Mayer L Targan S Domschke W Recent understanding of IBD pathogenesis: Implications for future therapies Inflamm Bowel Dis 2006, 12:1068-83. 10.1097/ 01.mib.0000235827.21778.d5 17075348
7. Satsangi J Parkes M Louis E Hashimoto L Kato N Welsh K Terwilliger JD Lathrop GM Bell JI Jewell DP Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 Nat Genet 1996, 14:199-202. 10.1038/ng1096-199 8841195
8. Schwab M Schaeffeler E Marx C Fromm MF Kaskas B Metzler J Stange E Herfarth H Schoelmerich J Gregor M Walker S Cascorbi I Roots I Brinkmann U Zanger UM Eichelbaum M Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis Gastroenterology 2003, 124:26-33. 10.1053/gast.2003.50010 12512026
9. Lawrance IC Fiocchi C Chakravarti S Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes Hum Mol Genet 2001, 10:445-456. [9] 10.1093/hmg/10.5.445 11181568
10. Roussomoustakaki M Satsangi J Welsh K Louis E Fanning G Targan S Landers C Jewell DP Genetic markers may predict disease behavior in patients with ulcerative colitis Gastroenterology 1997, 112:1845-53. 10.1053/ gast.1997.v112.pm9178675 9178675
11. Mah N Thelin A Lu T Nikolaus S Kuhbacher T Gurbuz Y Eickhoff H Kloppel G Lehrach H Mellgard B Costello CM Schreiber S A comparison of oligonucleotide and cDNA-based microarray systems Physiol Genomics 2004, 16:361-370. 10.1152/physiolgenomics.00080.2003 14645736
12. Tan PK Downey TJ Spitznagel EL Jr Xu P Fu D Dimitrov DS Lempicki RA Raaka BM Cam MC Evaluation of gene expression measurements from commercial microarray platforms Nucleic Acids Res 2003, 31:5676-5684. 206463 14500831 10.1093/nar/gkg763
13. Dieckgraefe BK Stenson WF Korzenik JR Swanson PE Harrington CA Analyzis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays Physiol Genomics 2000, 4:1-11. 11074008
14. Flach CF Eriksson A Jennische E Lange S Gunnerek C Lönnroth I Detection of elafin as a candidate marker for ulcerative colitis by whole-genome microarray screening Inflamm Bowel Dis 2006, 12:837-847. 10.1097/01.mib.0000232469.23574.11 16954802
15. Sloan JL Mager S Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+) J Biol Chem 1999, 274:23740-23745. 10.1074/jbc.274.34.23740 10446133
16. Wachsmuth ED Differentiation of epithelial cells in human jejunum: localization and quantification of aminopeptidase, alkaline phosphatase and aldolase isozymes in tissue sections Histochemistry 1976, 48:101-109. 10.1007/BF00494548 955981
17. Simpson AJ Maxwell AI Govan JR Haslett C Sallenave JM Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens FEBS Lett 1999, 452:309-313. 10.1016/S0014-5793(99)00670-5 10386612
18. Schmid M Fellermann K Fritz P Wiedow O Stange EF Wehkamp J Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease J Leukoc Biol 2007, 81:907-915. 10.1189/jlb.0906581 17200145
19. Silverberg MS Satsangi J Ahmad T Arnott ID Bernstein CN Brant SR Caprilli R Colombel JF Gasche C Geboes K Jewell DP Karban A Loftus EV Jr Pena AS Ridell RH Sachar DB Schreiber S Steinhart AH Targan SR Vermeire S Warren BF Toward an integrated clinical, molecular and serologic classification of inflammatory bowel disease: Report from a working Party of the 2005 Montreal World congress of gastroenterology Can J Gastroenterology 2005, 19(suppl A):5-36.
20. Flach CF Lange S Jennische E Lönnroth I Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa FEBS Lett 2004, 561:122-126. 10.1016/S0014-5793(04)00139-5 15013762
21. Sartor RB Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis Nat Clin Pract Gastroenterol Hepatol 2006, 3:390-407. 10.1038/ncpgasthep0528 16819502
22. Desai D Faubion WA Sandborn WJ Review article: Biological activity markers in inflammatory bowel disease Aliment Pharmacol Ther 2007, 25(3):247-55. 17217454
23. Morrison AC Wilson CB Ray M Correll PH Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide J Immunol 172:1825-1832. 2004, Feb 1 14734766